QCI Interpret for Oncology

50 to 500 genes: Scale-up to comprehensive genomic profiling

108 views
July 13, 2022
In this webinar, we present a workflow-agnostic, informatics software solution that enables clinical diagnostic labs to scale to CGP while reducing cost, time, and labor. Already used and trusted to interpret over 3 million patient cases worldwide, this software solution leverages the world’s largest and fastest-growing knowledge base to simplify and accelerate variant interpretation and build custom, patient-specific reports with the latest diagnostic and prognostic information, as well as biomarker-directed therapies and clinical trials.

In this webinar, you will:

Learn how to overcome unique challenges of CGP, including identifying incidental germline findings and interpreting co-occurring variants.
See why 90,000 users trust QIAGEN Digital Insights for knowledge curation—how we have built the most trusted, fastest growing knowledge base and why our curation process is unrivalled in the industry.
Receive step-by-step guide of how to perform CGP and go from VCF to final report with greater speed, precision, and confidence (all registrants can receive custom report if VCF files are provided).
Qualify for a complimentary demonstration and trial of this industry-leading software to see how your lab can scale to CGP while reducing costs, time, and labor.

Related videos

QCI Interpret for Oncology

FASTQ to final report: Ultra-fast workflow for CGP

195 views July 21, 2022

As our molecular knowledge of cancer continually evolves, a new era in cancer...

QCI Interpret for Oncology

Comparison of methods in routine somatic diagnostics

105 views April 12, 2022

Dr. Mattia Schmid from UniLabs, Switzerland compares the methods of molecular...

QCI Interpret for Oncology

Gaining insights with transcriptomic profiling and mechanistic modeling

251 views June 11, 2021

In this webinar, Moritz Schütte, head of next-generation sequencing data...

QCI Interpret for Oncology

Going beyond: Molecular evidence for off-label therapy use

106 views June 02, 2021

Kathryn Bungartz, Ph.D., Associate StaffField Application Scientist, QIAGEN...